PT  - JOURNAL ARTICLE
AU  - Piercarlo Sarzi-Puttini
AU  - Valentina Varisco
AU  - Maria Chiara Ditto
AU  - Maurizio Benucci
AU  - Fabiola Atzeni
TI  - Psoriatic Arthritis Registries
AID  - 10.3899/jrheum.150631
DP  - 2015 Nov 01
TA  - The Journal of Rheumatology
PG  - 30--32
VI  - 93
4099  - http://www.jrheum.org/content/93/30.short
4100  - http://www.jrheum.org/content/93/30.full
SO  - J Rheumatol2015 Nov 01; 93
AB  - The introduction of new biological drugs for the treatment of rheumatoid arthritis and spondyloarthritis has led to the creation of a number of registries in Europe and the United States. Most of them are sponsored by national rheumatology societies, and provide information that is useful in clinical practice concerning the clinical characteristics, efficacy, and safety of all licensed biological drugs. Their findings also help to improve our understanding of the quality of life and working ability of patients receiving biological drugs, and suggest methods for allocating resources. However, there are only a few registries for psoriatic arthritis, and efforts should be made to increase their number to obtain further reliable and useful data.